Planet 13 Holdings (PLNH) Depreciation & Amortization (CF) (2021 - 2026)

Planet 13 Holdings' (PLNH) quarterly Depreciation & Amortization (CF) came in at $2.2 million in Q1 2026, down 27.83% year-on-year from $3.1 million in Q1 2025, and down 5.86% on a QoQ basis from $2.4 million in Q4 2025.

Planet 13 Holdings (PLNH) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $2.2 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 27.83% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $10.5 million, a 21.79% decrease from a year earlier, with the FY2025 full-year figure at $11.4 million, down 15.02% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $2.2 million, down from $2.4 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PLNH reached as high as $3.6 million in Q4 2024 and fell as low as $2.2 million in Q1 2026.
  • Historically, Depreciation & Amortization (CF) has averaged $3.0 million across 5 years, with a median of $3.0 million in 2023.
  • Across the five-year window, Depreciation & Amortization (CF) jumped 173.95% in 2022 and tumbled 34.12% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $3.1 million in 2022, then slipped by 4.5% to $3.0 million in 2023, then rose by 21.03% to $3.6 million in 2024, then tumbled by 34.12% to $2.4 million in 2025, then slipped by 5.86% to $2.2 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $2.2 million in Q1 2026, $2.4 million in Q4 2025, and $2.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn 2.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.22 Mn
Mar 31, 2026 2.22 Mn
Dec 31, 2025 2.36 Mn
Dec 31, 2025 2.36 Mn
Sep 30, 2025 2.75 Mn
Sep 30, 2025 2.75 Mn
Jun 30, 2025 3.20 Mn
Jun 30, 2025 3.20 Mn
Mar 31, 2025 3.08 Mn
Mar 31, 2025 3.08 Mn
Dec 31, 2024 3.59 Mn
Dec 31, 2024 3.59 Mn
Sep 30, 2024 3.58 Mn
Sep 30, 2024 3.58 Mn
Jun 30, 2024 3.23 Mn
Jun 30, 2024 3.23 Mn
Mar 31, 2024 3.02 Mn
Mar 31, 2024 3.02 Mn
Dec 31, 2023 2.96 Mn
Dec 31, 2023 2.96 Mn